Study Finds A Strong Link Between Cell Phone Use and Cancer Biography

The dangers of cell phone use have long been debated but for the first time a clear connection between cell phone use and higher risk of cancer has been established in a study by Tel Aviv University.

Sci
entists from TAU, Rabin Medical Center and the Technion examined the saliva content of 20 long-term heavy cell phone users, defined as a mean of 12 years of 30 hours per week of use. Their spit was compared to a control group of mostly deaf people who do not use a cell phone or use them only for text messaging.

In their study, published in the scientific journal Antioxidants and Redox Signaling, the researchers noted:

"Increasing use of mobile phones creates growing concerns regarding harmful effects of radiofrequency nonionizing electromagnetic radiation on human tissues located close to the ear, where phones are commonly held for long periods of time."

They concluded that compared to the non-users, cell phone users' saliva showed much higher indications of oxidative stress, regarded as a major risk factor for cancer.

How does cell phone use increase the risk of cancer?
Cell phones emit radiation. There are two types of radiation: ionizing and non-ionizing radiation. Cell phones emit radiation of the non-ionizing type. This means, there isn't sufficient energy to knock an electron off a molecule. This kind of radiation was once considered harmless. But a growing number of studies like this one are pointing to numerous adverse biological effects of non-ionizing radiation.

Oxidative stress, as found in the Tel Aviv cell phone study, reflects an imbalance between the systemic manifestation of reactive oxygen species and the ability to detoxify or repair the resulting damage. It's a process that damages human cells, including DNA, through the creation of toxic peroxide and free radicals. This damage caused by oxidative stress is linked to cellular and genetic mutations, which can cause the development of tumors.

Evidence building

This isn't the first time cell phones have been linked to cancer. In 2011 the World Health Organization, concluded that emissions from cell phones are "possibly carcinogenic" and classified them as a possible "Category 2B carcinogen."

The results of the Tel Aviv study don't reveal a conclusive "cause and effect" relationship between cellular phone use and cancer but they add to the building evidence that cell phone use is harmful. The results also point to a new direction for further research.

A potential avenue of future research would be to analyze an individual's saliva prior to cell phone use, and then again after several intense minutes of cell phone use. The author of the Tel Aviv study, Dr. Hamzany, says this would allow researchers to see if there is an immediate response such as a rise in molecules that indicate oxidative stress.

As evidence on the harmful effects of cell phones mounts, so does the number of people using these handheld devices.

Researchers from India have proven in a randomized clinical study using international protocols that an ancient Ayurveda remedy for anxiety outperformed the benzodiazepine drug Clonazepam (Klonopin) in relieving severe anxiety.

The researchers, from India's National Institute of Mental Health and Neurosciences (NIMHANS), tested 72 patients in a hospital setting who were diagnosed with severe generalized anxiety disorder using the Hamilton Anxiety Rating Scale (HARS). The test subjects were all adults between 20 and 55 years old of both sexes and most had experienced their anxiety disorder for seven years or more. They were also diagnosed with comorbid generalized social phobia.

The researchers randomly divided the patients into three groups. One group was given the standard anti-anxiety medication Clonazepam (Klonopin) at the standard prescriptive dose of .75 milligrams per day (.25mg morning, .50mg night). Another group received 200 milligrams of an Ayurvedic herbal remedy called Manasamitra Vataka (also Manasamitra Vatakam) – in two doses (100 mg each).

A third group was given the same dosage of Manasamitra Vataka but this was added to the patients' receiving an Ayurvedic treatment called Shirodhara therapy – where warmed Brahmi taila oil is poured onto the forehead of the patient.

The patients each continued their treatments for 30 days, and were evaluated at day 15 and day 30. Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) testing was conducted along with Hamilton Anxiety Rating Scale (HARS) analysis of the patients' progress.

At the end of thirty days' treatment, the researchers found that the Manasamitra Vataka group on average had a 73% improved disposition according to the BAI testing, while the Clonazepam group on average improved 67% using the same scale. Using the HARS test scale, those patients receiving the Manasamitra Vataka plus the Shirodhara therapy saw a 91% average improvement in symptoms, while the Clonazepam group experienced a 76% improvement.

The researchers concluded that the Ayurvedic treatment not only exceeded the performance of the benzodiazepine, but came with no side effects. The researchers noted: